Nociceptin/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease.

about

PAI-1-derived peptide EEIIMD prevents hypoxia/ischemia-induced aggravation of endothelin- and thromboxane-induced cerebrovasoconstriction.The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.

P2860

Q35580953-301858A2-1C5A-481D-ADA1-EC3DC9830675 Q37397573-4F03DE2D-AADF-4115-8D7F-CCF074E9C5FC

P2860

Nociceptin/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease.

Item

http://www.wikidata.org/entity/Q37808767

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Nociceptin/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease.

@en

Nociceptin/orphanin phenylalanine glutamine

@nl

type

Item

label

Nociceptin/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease.

@en

Nociceptin/orphanin phenylalanine glutamine

@nl

prefLabel

Nociceptin/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease.

@en

Nociceptin/orphanin phenylalanine glutamine

@nl

P1476

Nociceptin/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease.

@en

P2093

William M Armstead

http://www.w3.org/2001/XMLSchema#string

P2860

Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor

Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain

Nociceptin receptor activation produces nitric oxide-mediated systemic hypotension

Age dependent endothelin contribution to NOC/oFQ induced impairment of NMDA cerebrovasodilation after brain injury.

Stimulation of sensory neuropeptide release by nociceptin/orphanin FQ leads to hyperaemia in acutely inflamed rat knees.

Studies of the cardiovascular effects of nociceptin and related peptides.

Nociceptin/orphanin FQ and neurotransmitter release in the central nervous system.

Neurohumoral effects of orphanin FQ/nociceptin: relevance to cardiovascular and renal function.

Nociceptin induced inhibition of K+ evoked glutamate release from rat cerebrocortical slices

Animate models of human head injury.

P304

23-28

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1755-5922.2010.00241.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47754568

http://www.w3.org/2001/XMLSchema#string

P698

21070618

http://www.w3.org/2001/XMLSchema#string

P921

nociceptin

Nociceptin/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease.

about

P2860

P2860

Nociceptin/orphanin phenylalanine glutamine (FQ) receptor and cardiovascular disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921